Dollars in thousands
| IC | FY 2018 Operating |
FY 2019 Operating Estimate |
Percent Change |
|---|---|---|---|
| NCI | $5,943,706 | $6,143,892 | 3.4% |
| NIAID* | $5,268,307 | $5,523,324 | 4.8% |
| NHLBI | $3,374,283 | $3,488,335 | 3.4% |
| NHGRI | $556,764 | $575,579 | 3.4% |
| NCATS | $760,710 | $806,373 | 6.0% |
| NIGMS | $2,781,024 | $2,872,780 | 3.3% |
| NIA | $2,571,502 | $3,083,410 | 19.9% |
| NIDA | $1,374,374 | $1,419,844 | 3.3% |
| Other ICs | $12,400,202 | $12,852,788 | 3.6% |
| Subtotal | $35,030,872 | $36,766,325 | 5.0% |
| OD | $1,914,345 | $2,112,675 | 10.4% |
| Buildings and Facilities | $128,863 | $200,000 | 55.2% |
| Total** | $37,074,080 | $39,079,000 | 5.4% |
* Includes an additional $37 million to NIAID for Antibiotic/Antimicrobial Resistance research and $40 million for Universal Influenza Vaccine Research.
** Total NIH program level excludes mandatory funding for type I diabetes.